- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Hypsarrhythmia and/or infantile spasms
- Meeting Date: May 2021
- Public Summary Document (PSD) May 2021 PBAC Meeting - (PDF 816KB)
- Public Summary Document (PSD) May 2021 PBAC Meeting - (Word 36KB)
Tetracosactide – May 2021
Tetracosactide: Compound depot injection 1 mg in 1 mL; Synacthen®
Last updated
10 September 2021